In the metastatic microenvironment, the upregulation of fibroblast-derived IL33 expression triggers type 2 inflammation; mediates the recruitment of eosinophils, neutrophils and inflammatory monocytes to the lung; and promotes breast cancer metastasis [49]. Here, IL33 is linked to breast cancer.